Please use this identifier to cite or link to this item:
|Title:||Drug-resistant tuberculosis: Pediatric guidelines|
H. Simon Schaaf
Ben J. Marais
Tobias R. Kollmann
The University of British Columbia
Department of Pediatrics
Children's and Women's Health Centre of British Columbia
Hospital for Sick Children University of Toronto
|Citation:||Pediatric Infectious Disease Journal. Vol.30, No.6 (2011), 501-505|
|Abstract:||Drug-resistant Mycobacterium tuberculosis (TB) infection represents a serious and growing problem. For patients infected or suspected of being infected with multidrug or extensively drug-resistant TB, several medications have to be given simultaneously for prolonged periods. Here, we review the literature on treatment and monitoring of adverse effects of pediatric drug-resistant TB therapy in a high resource, low TB burden setting. Copyright © 2011 by Lippincott Williams & Wilkins.|
|Appears in Collections:||Scopus 2011-2015|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.